{"id":393715,"date":"2025-09-03T05:03:16","date_gmt":"2025-09-03T05:03:16","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/393715\/"},"modified":"2025-09-03T05:03:16","modified_gmt":"2025-09-03T05:03:16","slug":"common-heart-attack-drug-may-raise-death-risk-in-some-women-study-to-read-more-from-the-study-inshorts-inshorts","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/393715\/","title":{"rendered":"Common heart attack drug may raise death risk in some women: Study | To read more from the study | Inshorts – Inshorts"},"content":{"rendered":"
    \n
  1. Common heart attack drug may raise death risk in some women: Study | To read more from the study | Inshorts<\/a>  Inshorts<\/li>\n
  2. Common heart drug taken by millions found useless, possibly risky<\/a>  ScienceDaily<\/li>\n
  3. Doctors may need to rethink decades of routine beta blocker use for some patients after a heart attack, studies suggest<\/a>  ABC News<\/li>\n
  4. Research on beta blockers shows conflicting results<\/a>  Semafor<\/li>\n
  5. This common drug used to treat heart attacks could have fatal consequences for women: new study<\/a>  The Independent<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Common heart attack drug may raise death risk in some women: Study | To read more from the…\n","protected":false},"author":2,"featured_media":393716,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[11413,1500,29923,9409,9680,4044,10957,6579,105,9681,301,1501,3611,4326,12,9677,68580,2846,57006,5882,16,15,1292,9679,9678,9676],"class_list":{"0":"post-393715","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-attack","9":"tag-breaking-news","10":"tag-common","11":"tag-current-affairs","12":"tag-current-news","13":"tag-daily-news","14":"tag-death","15":"tag-drug","16":"tag-health","17":"tag-health___fitness","18":"tag-heart","19":"tag-latest-news","20":"tag-local-news","21":"tag-medication","22":"tag-news","23":"tag-news-online","24":"tag-raise","25":"tag-risk","26":"tag-some","27":"tag-study","28":"tag-uk","29":"tag-united-kingdom","30":"tag-women","31":"tag-9679","32":"tag-9678","33":"tag-9676"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115138619410296251","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/393715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=393715"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/393715\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/393716"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=393715"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=393715"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=393715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}